BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8485500)

  • 1. Comment on "An improved method of direct labeling monoclonal antibodies with 99mTc" by M. M. Alauddin, L. A. Khawli and A. L. Epstein, Nucl. Med. Biol. 19, 445-454.
    Mather SJ
    Nucl Med Biol; 1993 Apr; 20(3):375-6. PubMed ID: 8485500
    [No Abstract]   [Full Text] [Related]  

  • 2. Solid phase labeling of monoclonal antibodies with 99mTc using two bifunctional photocleavable reagents.
    Ranadive GN; Bloomer WD
    Nucl Med Biol; 1995 Jul; 22(5):607-12. PubMed ID: 7581170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct 99mTc labeling of monoclonal antibodies: radiolabeling and in vitro stability.
    Garron JY; Moinereau M; Pasqualini R; Saccavini JC
    Int J Rad Appl Instrum B; 1991; 18(7):695-703. PubMed ID: 1787078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium.
    Griffiths GL; Goldenberg DM; Jones AL; Hansen HJ
    Bioconjug Chem; 1992; 3(2):91-9. PubMed ID: 1515475
    [No Abstract]   [Full Text] [Related]  

  • 5. A new method of technetium-99m labeling of monoclonal antibodies through sugar residues. A study with TAG-72 specific CC-49 antibody.
    Ranadive GN; Rosenzweig HS; Epperly MW; Seskey T; Bloomer WD
    Nucl Med Biol; 1993 Aug; 20(6):719-26. PubMed ID: 8401372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction-mediated technetium-99m labeling of monoclonal antibodies.
    Mather SJ; Ellison D
    J Nucl Med; 1990 May; 31(5):692-7. PubMed ID: 2341907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method for labelling of monoclonal antibodies and their fragments with technetium-99m.
    Joiris E; Bastin B; Thornback JR
    Int J Rad Appl Instrum B; 1991; 18(3):353-6. PubMed ID: 2071447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody.
    Schwarz SW; Connett JM; Anderson CJ; Rocque PA; Philpott GW; Guo LW; Welch MJ
    Nucl Med Biol; 1994 May; 21(4):619-26. PubMed ID: 9234319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labeling of anti-tumor antibodies and antibody fragments with Tc-99m.
    Hansen HJ; Jones AL; Grebenau R; Kunz A; Goldenberg DM
    Cancer Treat Res; 1990; 51():233-44. PubMed ID: 1977447
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct 99m Tc labeling of Herceptin (trastuzumab) by 99m Tc(I) tricarbonyl ion.
    Chen WJ; Yen CL; Lo ST; Chen KT; Lo JM
    Appl Radiat Isot; 2008 Mar; 66(3):340-5. PubMed ID: 17996452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new method for protein labeling with 99mTc.
    Blok D; Feitsma RI; Wasser MN; Nieuwenhuizen W; Pauwels EK
    Int J Rad Appl Instrum B; 1989; 16(1):11-6. PubMed ID: 2714995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m labeling of murine monoclonal antibody fragments.
    Rhodes BA; Zamora PO; Newell KD; Valdez EF
    J Nucl Med; 1986 May; 27(5):685-93. PubMed ID: 3086522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide-based bifunctional chelating agent for 99mTc- and 186Re-labeling of monoclonal antibodies.
    Ram S; Buchsbaum DJ
    Cancer; 1994 Feb; 73(3 Suppl):769-73. PubMed ID: 8306258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc labeling of highly potent small peptides.
    Liu S; Edwards DS; Barrett JA
    Bioconjug Chem; 1997; 8(5):621-36. PubMed ID: 9327124
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
    Smellie WJ; Dean CJ; Sacks NP; Zalutsky MR; Garg PK; Carnochan P; Eccles SA
    Cancer Res; 1995 Dec; 55(23 Suppl):5842s-5846s. PubMed ID: 7493357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC.
    Linder KE; Wen MD; Nowotnik DP; Malley MF; Gougoutas JZ; Nunn AD; Eckelman WC
    Bioconjug Chem; 1991; 2(3):160-70. PubMed ID: 1932215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalies in reduction-mediated technetium-99m labelling of monoclonal antibodies.
    Pimm MV; Rajput RS; Frier M; Gribben SJ
    Eur J Nucl Med; 1991; 18(12):973-6. PubMed ID: 1778209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for labeling monoclonal antibodies and antibody-like molecules with technetium-99m.
    Delmon-Moingeon LI; Mahmood A; Davison A; Jones AG
    J Nucl Biol Med (1991); 1991; 35(1):47-59. PubMed ID: 1932176
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of available in vitro 99mTc-RBC labeling techniques: a Canadian perspective.
    Toda E; Ginj M
    J Nucl Med Technol; 2014 Dec; 42(4):243-4. PubMed ID: 25472511
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct 99mTc-labeling of antibodies by sodium dithionite reduction, and role of ascorbate as a stabilizer in cysteine challenge.
    Qi P; Muddukrishna SN; Torok-Both R; Rahn J; Chen A
    Nucl Med Biol; 1996 Aug; 23(6):827-35. PubMed ID: 8940727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.